Home Page
USFDA issues warning letter to Aurobindo Pharma's Telangana facility
Aurobindo Pharma said it remains committed to working closely with the US FDA and continues to enhance its compliance on an ongoing basis
Originally published by Home Page — read the full article at the source →
Shown as published in the source's RSS feed. Formatting and images are simplified for readability here — follow the source link above for the original article.